The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. (October 2022) |
DnaNudge is a British company specializing in DNA testing. In late 2020, during the COVID-19 pandemic, it introduced COVID Nudge, a rapid RT-PCR test for COVID-19.[1] The device uses a disposable sample capsule that is placed into a sample processor box, and gives results in 90 minutes.[2] As of August 2020, the British government had ordered 5000 of the sample processor boxes.[3]
| Industry | Healthcare |
|---|---|
| Headquarters | United Kingdom |
| Website | dnanudge |
Sir Richard Sykes joined its board in 2021.[4]
Origins edit
The company was co-founded by Chris Toumazou.[4]
See also edit
- Imperial College London, associated institution[5]
References edit
- ^ Gibani, Malick M.; Toumazou, Christofer; Sohbati, Mohammadreza; Sahoo, Rashmita; Karvela, Maria; Hon, Tsz-Kin; Mateo, Sara De; Burdett, Alison; Leung, K. Y. Felice; Barnett, Jake; Orbeladze, Arman (17 September 2020). "Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study". The Lancet Microbe. 1 (7): e300–e307. doi:10.1016/S2666-5247(20)30121-X. ISSN 2666-5247. PMC 7498257. PMID 32964211.
- ^ Gallagher, James (18 September 2020). "Simple Covid test gives results in 90 minutes". BBC News. Retrieved 18 September 2020.
- ^ "Roll-out of 2 new rapid coronavirus tests ahead of winter". GOV.UK. Retrieved 18 September 2020.
- ^ a b "Sir Richard Sykes Appointed Chairman Elect of Genetic Testing Innovator DnaNudge". www.businesswire.com. 15 December 2021. Retrieved 29 December 2021.
- ^ "Who are DnaNudge Ltd?". Imperial College London.
External links edit
 | This article about a company of the UK is a stub. You can help Wikipedia by expanding it. |
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |